Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
Technical Sentiment
Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Adaptimmune Therapeutics’s (ADAPY) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Buy.
Adaptimmune Therapeutics’s (ADAPY) 20-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics’s (ADAPY) 50-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics (ADAPY) Pivot Points
Classic
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Fibonacci
0.02
0.02
0.02
0.02
0.02
0.02
0.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (ADAPY) Moving Averages
MA5
0.02Sell
0.02Sell
MA10
0.02Sell
0.02Sell
MA20
0.02Sell
0.02Sell
MA50
0.03Sell
0.03Sell
MA100
0.05Sell
0.05Sell
MA200
0.11Sell
0.12Sell
Adaptimmune Therapeutics’s (ADAPY) 10-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics’s (ADAPY) 100-Day exponential moving average is 0.05, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 50-day simple moving average is 0.03, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 100-day simple moving average is 0.05, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 200-day simple moving average is 0.11, creating a Sell signal.
Adaptimmune Therapeutics (ADAPY) Technical Indicators
RSI (14)
39.95
Neutral
STOCH (9,6)
52.78
Neutral
STOCHRSI (14)
52.08
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
73.33
Sell
Williams %R
-68.75
Buy
CCI (14)
-149.84
Buy
ATR (14)
0.02
-
Ultimate Oscillator
62.35
Neutral
ROC
-66.67
Sell
Adaptimmune Therapeutics’s (ADAPY) Relative Strength Index (RSI) is 39.95, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Trend Strength Indicator (ADX) is 73.33, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) Commodity Channel Index (CCI) is -149.84, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAPY) Price Rate of Change (ROC) is -66.67, creating a Sell signal.
FAQ
Is ADAPY a Buy, Hold, or Sell?
Based on ADAPY’s technical indicators, ADAPY is a Strong Sell.
What is ADAPY’s RSI (14)?
ADAPY’s RSI (14) is 39.95, which suggests ADAPY is a Neutral.
What is ADAPY’s MACD?
ADAPY’s MACD is >-0.01, which suggests ADAPY is a Buy.
What is ADAPY’s 5-day moving average?
ADAPY’s 5-day moving average is 0.02, which suggests ADAPY is a Sell.
What is ADAPY’s 20-day moving average?
ADAPY 20-day moving average is 0.02, which suggests ADAPY is a Sell.
What is ADAPY’s 50-day moving average?
ADAPY’s 50-day moving average is 0.03, which suggests ADAPY is a Sell.
What is ADAPY’s 200-day moving average?
ADAPY’s 200-day moving average is 0.11, which suggests ADAPY is a Sell.
What is ADAPY’s Williams % R (14)?
ADAPY’s Williams % R (14) is -68.75, which suggests ADAPY is a Buy.
What is ADAPY’s CCI (14)?
ADAPY’s CCI (14) is -149.84, which suggests ADAPY is a Buy.